Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > J Mark Gergen > Profile

J Mark Gergen

Affiliations

  • President And Ceo at Poseida Therapeutics Inc. (PSTX), 2025-01-08
  • Svp, Chief Operating Officer at Halozyme Therapeutics Inc (HALO), 2017-02-24
  • Executive Vp, Coo at Mirati Therapeutics Inc. (MRTX), 2016-01-26
  • Svp, Corporate Development at Amylin Pharmaceuticals Inc (AMLN), 2012-08-10
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PSTX $9.46 30,000 $283,866.00 651,291 2024-12-10 Filing
PSTX $9.27 30,000 $278,100.00 651,291 2024-11-26 Filing
MRTX $25.92 10,000 $259,211.00 5,748 2016-01-15 Filing
AMLN $17.11 1,846 $31,585.06 53,814 2012-03-01 Filing
AMLN $17.03 7,518 $128,033.04 54,826 2012-02-23 Filing